Maria Gasi serves as the Director of Research Programs at UT MD Anderson Cancer Center, where she leverages over 20 years of extensive experience in research administration and development. In her current role, Maria is instrumental in managing the implementation of systems, policies, and procedures...
Maria Gasi serves as the Director of Research Programs at UT MD Anderson Cancer Center, where she leverages over 20 years of extensive experience in research administration and development. In her current role, Maria is instrumental in managing the implementation of systems, policies, and procedures that govern the development, planning, and management of grant proposal budgets and contractual agreements. Her expertise in financial management and operational planning ensures that research initiatives are not only well-funded but also strategically aligned with the institution's long-term goals.
One of Maria's key projects involves spearheading the growth of research programs through meticulous long-range planning, which includes assessing changes in research priorities, space allocation, and financial forecasting. Her ability to identify and determine eligibility for diverse funding sources has significantly enhanced the center's capacity to secure grants, thereby fostering an environment of innovation and discovery.
Maria is also committed to professional development within the research administration community. She actively conducts training sessions and workshops aimed at enhancing the skills of her team and other stakeholders, emphasizing the importance of effective communication and customer service in research administration. Her public speaking engagements further showcase her leadership abilities, as she shares insights on best practices in research proposal development and community outreach initiatives.
With a strong foundation in business administration, Maria Gasi continues to make a profound impact at UT MD Anderson Cancer Center, driving forward-thinking strategies that not only streamline research processes but also cultivate a culture of excellence in cancer research.
